osama, N., Attia, S., Farmawy, M., Nemmat, A., Shalash, M. (2017). THE USE OF BOTULINUM TOXIN INJECTION IN THE MANAGEMENT OF MYOFASCIAL PAIN DYSFUNCTION SYNDROME. test, 63(Issue 4 - October (Oral Surgery)), 3069-3075. doi: 10.21608/edj.2017.76102
Nashwa osama; Sayed Attia; Mohamed Farmawy; Amany Hussien Nemmat; Mahmoud Shalash. "THE USE OF BOTULINUM TOXIN INJECTION IN THE MANAGEMENT OF MYOFASCIAL PAIN DYSFUNCTION SYNDROME". test, 63, Issue 4 - October (Oral Surgery), 2017, 3069-3075. doi: 10.21608/edj.2017.76102
osama, N., Attia, S., Farmawy, M., Nemmat, A., Shalash, M. (2017). 'THE USE OF BOTULINUM TOXIN INJECTION IN THE MANAGEMENT OF MYOFASCIAL PAIN DYSFUNCTION SYNDROME', test, 63(Issue 4 - October (Oral Surgery)), pp. 3069-3075. doi: 10.21608/edj.2017.76102
osama, N., Attia, S., Farmawy, M., Nemmat, A., Shalash, M. THE USE OF BOTULINUM TOXIN INJECTION IN THE MANAGEMENT OF MYOFASCIAL PAIN DYSFUNCTION SYNDROME. test, 2017; 63(Issue 4 - October (Oral Surgery)): 3069-3075. doi: 10.21608/edj.2017.76102

THE USE OF BOTULINUM TOXIN INJECTION IN THE MANAGEMENT OF MYOFASCIAL PAIN DYSFUNCTION SYNDROME

Egyptian Dental Journal
Article 6, Volume 63, Issue 4 - October (Oral Surgery), October 2017, Pages 3069-3075    PDF (1.02 M)
Document Type: Original Article
DOI: 10.21608/edj.2017.76102
Authors
Nashwa osama1; Sayed Attia2; Mohamed Farmawy3; Amany Hussien Nemmat4; Mahmoud Shalash4
1Oral Surgery and Medicine Department, National Research Centre, Egypt
2Professor of Oral & Maxillofacial Surgery, Cairo University
3Lecturer of oral & Maxillofacial Surgery, Cairo University
4Oral Surgery and Medicine Department, National Research Centre, Egypt.
Abstract
Objectives: To evaluate the short-term effect of the botulinum toxin, type A (BTX-A) injection for the treatment of myofascial pain dysfunction syndrome.
Materials & Methods: Foueteen female patients suffering from myofascial pain dysfunction syndrome were included in this study. For all patients both the masseter and temporalis muscles were injected once with 20-30 Units of BTX-A respectively and followed up for three months. Follow up included clinical assessment of maximal inter-incisal opening, range of lateral movement and visual analogue scale for pain. Electromyography (EMG) images were ordered pre-operatively and at the end of 3 months’ period to quantify the changes in muscle activity.
Results: Results of the present study showed resolution of pain in all patients upon completing the follow up period.
Conclusion: Within the limits of this study BTX-A can be used effectively for the treatment of myofacial pain dysfunction syndrome.
Statistics
Article View: 158
PDF Download: 326